NCT01123954

Evaluating the Safeness of Trivalent Subunit Inactivated Influenza Vaccines in Preventing Flu on Vietnamese Volunteers

• Status: Completed
• Phase: Phase 2
• Study type: Interventional
• Enrollment: 33 (actual)
• Sponsor: Novartis Vaccines · Industry
• Sex: All
• Age: 1 Year – 45 Years
• Healthy volunteers: Accepted

Summary

The present study will evaluate the safety in healthy people aged 1- 45 years (male and female) after single intramuscular (IM) dose of trivalent subunit inactivated influenza vaccine till the 30-days follow-up period.

Conditions

• Seasonal Influenza

Interventions

Type	Name	Description
BIOLOGICAL	Seasonal flu vaccine	This phase II is performed as a monocenter study site in a population of healthy subjects aged 1 to 45 years. Enrolled subjects received one single IM dose of trivalent subunit inactivated influenza vaccine during the vaccination visit, according to the study protocol (follow-up period: 30 days)

Timeline

• Start date: 2010-01-01
• Primary completion: 2010-03-01
• Completion: 2010-04-01
• First posted: 2010-05-14
• Last updated: 2011-12-14

Locations

1 site across 1 country: Vietnam